Document is current
Any future updates will be listed below
-
Authors
Skjøth-Rasmussen, Jane
Azam, Aleena
Larsen, Carl Christian
Scheie, David
Juhl, Karina
Kjaer, Andreas
-
Funding
Funding for this research was provided by:
læge sophus carl emil friis og hustru olga doris friis' legat
- License Information
-
More Information
Article History
Received: 22 June 2021
Accepted: 27 October 2021
First Online: 8 November 2021
Declarations
:
: Informed consent was obtained from all individual participants included in the study and in particular the participant in the current case gave consent for publication.
: AK is an inventor of FG001 and co-founder of FluoGuide and Curasight that seek to commercialize uPAR-targeting technologies. KJ is an industrial postdoc at FluoGuide.JS is the principal investigator of the abovementioned trial.Author CCL declares no conflict of interest.Author AA declares no conflict of interest.Author DS declares no conflict of interest.
